R. Langer

6.4k total citations · 2 hit papers
59 papers, 4.4k citations indexed

About

R. Langer is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, R. Langer has authored 59 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Biomedical Engineering and 9 papers in Biomaterials. Recurrent topics in R. Langer's work include Protein purification and stability (6 papers), Electrospun Nanofibers in Biomedical Applications (6 papers) and Advancements in Transdermal Drug Delivery (5 papers). R. Langer is often cited by papers focused on Protein purification and stability (6 papers), Electrospun Nanofibers in Biomedical Applications (6 papers) and Advancements in Transdermal Drug Delivery (5 papers). R. Langer collaborates with scholars based in United States, Germany and Israel. R. Langer's co-authors include Nicholas A. Peppas, Joseph P. Vacanti, Alexander M. Klibanov, Joseph Kost, Kam W. Leong, Samir Mitragotri, Daniel S. Kohane, Jonathan H. Tsui, Henry R. Costantino and Kristi S. Anseth and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

R. Langer

58 papers receiving 4.2k citations

Hit Papers

New Challenges in Biomaterials 1994 2026 2004 2015 1994 2012 250 500 750

Peers

R. Langer
Weiyuan John Kao United States
Wayne R. Gombotz United States
Anthony M. Lowman United States
Matthew S. Shive United States
Moon Suk Kim South Korea
Soo‐Chang Song South Korea
Seongbong Jo United States
Andrew T. Metters United States
R. Langer
Citations per year, relative to R. Langer R. Langer (= 1×) peers V. Prasad Shastri

Countries citing papers authored by R. Langer

Since Specialization
Citations

This map shows the geographic impact of R. Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Langer more than expected).

Fields of papers citing papers by R. Langer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Langer. The network helps show where R. Langer may publish in the future.

Co-authorship network of co-authors of R. Langer

This figure shows the co-authorship network connecting the top 25 collaborators of R. Langer. A scholar is included among the top collaborators of R. Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Langer. R. Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langer, R.. (2025). My Struggles and Dreams as a Chemical Engineer. Annual Review of Chemical and Biomolecular Engineering. 16(1). 1–22.
2.
Krishnan, Siddharth, R. Langer, & Daniel G. Anderson. (2024). Materials approaches for next-generation encapsulated cell therapies. MRS Communications. 15(1). 21–33. 2 indexed citations
3.
Langer, R., Daniel G. Anderson, Omid Veiseh, Benjamin C. Tang, & Kathryn A. Whitehead. (2014). Managing diabetes with nanomedicine: challenges and opportunities. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations
4.
Farokhzad, Omid C., Jong‐Min Lim, Nicolas Bertrand, et al.. (2013). Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations
5.
Johnstone, Timothy C., Nora Kulak, Eric M. Pridgen, et al.. (2013). Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof onIn VivoProperties. ACS Nano. 7(7). 5675–5683. 78 indexed citations
6.
Liu, Jia, Tal Dvir, Lihua Jin, et al.. (2012). Macroporous Nanowire Nanoelectronic Scaffolds for Synthetic Tissues. Digital Access to Scholarship at Harvard (DASH) (Harvard University). 508 indexed citations breakdown →
7.
Bettinger, Christopher J., et al.. (2008). Enhancement of in vitro Capillary Tube Formation by Substrate Nanotopography. TechConnect Briefs. 2(2008). 222–225. 27 indexed citations
8.
Bettinger, Christopher J., et al.. (2007). Silk Fibroin Microfluidic Devices. Advanced Materials. 19(19). 2847–2850. 167 indexed citations
9.
Mitragotri, Samir, J. M. Farrell, Hua Tang, et al.. (2000). Determination of threshold energy dose for ultrasound-induced transdermal drug transport. Journal of Controlled Release. 63(1-2). 41–52. 126 indexed citations
10.
Anseth, Kristi S., Venkatram R. Shastri, & R. Langer. (1999). Photopolymerizable degradable polyanhydrides with osteocompatibility. Nature Biotechnology. 17(2). 156–159. 146 indexed citations
11.
Batycky, Richard, Justin Hanes, R. Langer, & David A. Edwards. (1997). A theory of erosion and macromolecule release from biodegrading microspheres. 167–168. 3 indexed citations
12.
Mooney, David, Kaoru Sano, Peter M. Kaufmann, et al.. (1997). Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. Journal of Biomedical Materials Research. 37(3). 413–420. 184 indexed citations
13.
Costantino, Henry R., Steven P. Schwendeman, Kai Griebenow, Alexander M. Klibanov, & R. Langer. (1996). The Secondary Structure and Aggregation of Lyophilized Tetanus Toxoid. Journal of Pharmaceutical Sciences. 85(12). 1290–1293. 53 indexed citations
14.
Sasisekharan, Ram, Deborah Leckband, Ranga Godavarti, et al.. (1995). Heparinase I from Flavobacterium heparinum: The Role of the Cysteine Residue in Catalysis as Probed by Chemical Modification and Site-Directed Mutagenesis. Biochemistry. 34(44). 14441–14448. 32 indexed citations
15.
Costantino, Henry R., R. Langer, & Alexander M. Klibanov. (1995). Aggregation of a Lyophilized Pharmaceutical Protein, Recombinant Human Albumin: Effect of Moisture and Stabilization by Excipients. Nature Biotechnology. 13(5). 493–496. 93 indexed citations
16.
Prausnitz, Mark R., Uwe Pliquett, R. Langer, & James C. Weaver. (1994). Rapid Temporal Control of Transdermal Drug Delivery by Electroporation. Pharmaceutical Research. 11(12). 1834–1837. 45 indexed citations
17.
Peppas, Nicholas A. & R. Langer. (1994). New Challenges in Biomaterials. Science. 263(5154). 1715–1720. 862 indexed citations breakdown →
18.
Moses, Marsha A. & R. Langer. (1991). Inhibitors of Angiogenesis. Nature Biotechnology. 9(7). 630–634. 88 indexed citations
19.
Langer, R., et al.. (1989). Immobilized enzyme cellulose hollow fibers: III. Physical properties and in vitro biocompatibility. Biotechnology and Bioengineering. 34(11). 1383–1390. 6 indexed citations
20.
Brem, Henry, A. Karim Kader, Jonathan I. Epstein, et al.. (1989). Biocompatibility of a Biodegradable, Controlled-Release Polymer in the Rabbit Brain. PubMed. 5(2). 55–65. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026